# Program 1 Architecture Review Track Phase B1 - Phase A Input Summary

Status: documentation-only summary of Phase A inputs for Phase B.

## Phase A position

Architecture Review Track Phase A opened a separate architecture review track after Phase Z. It did not continue as Phase Z+1 and did not reopen the Phase V-Z governance/prototype sequence.

Phase A kept Program 1 in pre-implementation hold.

## Inputs carried into Phase B

| Phase A input | Meaning for Phase B | Current limitation |
| --- | --- | --- |
| Synthetic-only architecture boundary | Phase B may use only synthetic examples and abstract placeholders | No real patient data, PHI/PII, or clinic-derived data |
| Permitted future discussion areas | Phase B may discuss conceptual architecture boundaries | No runtime implementation |
| Prohibited runtime paths | Phase B must preserve all prohibited clinical, production, and real-data paths | No implementation authorization |
| Data classification preview | Phase B must keep real, identifiable, PHI/PII, production, or clinic-derived data prohibited | No data processing approval |
| Read-only vs write-capable distinction | Phase B may distinguish concepts, not create runtime access | No read-only or write-capable runtime behavior |
| Human-in-the-loop responsibility preview | Phase B may describe future responsibility concepts | No clinical deployment or autonomous behavior |
| Future approval dependency map | Phase B must keep future approvals separate from documentation | No automatic exit from hold |

## Non-approval statement

Phase B uses Phase A inputs only for documentation. Phase B does not approve production use, real patient data, PHI/PII processing, clinical deployment, runtime implementation, go-live, or approval/clearance/override behavior.
